Navigation Links
Deltanoid Pharmaceuticals begins phase II osteoporosis study

Madison, Wis. - Deltanoid Pharmaceuticals, a privately held pharmaceutical company based in Madison, has begun a Phase 2 clinical study of 2MD, its lead osteoporosis compound.

The study is being conducted to determine whether 2MD can safely improve bone mineral density in postmenopausal women. Osteoporosis, a disease caused by the loss of norm......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 03/13/07


Page: 1

Related biology technology :

1. Deltanoid presses on with drug research
2. Deltanoid named to top-15 list of biotech companies
3. The Coming of Biotech Generic Pharmaceuticals
4. DeForest biodiesel plant begins production
5. Prodesse begins clinical trials for flu virus detection
6. Closing the income gap begins with education
7. Corporate control begins with a strong board
8. Emerging game developer begins work on prototypes
9. GE begins human trials for cancer detection agent
10. Now the real work begins
11. Esker begins automated faxing and mailing service
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2016)... 2016 ReportsnReports.com adds 2016 ... focus on US, EU, China ... the healthcare business intelligence collection of its growing ... report on the Flow Cytometry market spread across ... 282 tables and figures is now available at ...
(Date:4/26/2016)... , ... April 26, 2016 , ... The European ... been selected as one of three finalists for the European Inventor Award 2016 in ... innovation prize will be announced at a ceremony in Lisbon on June 9th. , ...
(Date:4/26/2016)... (PRWEB) , ... April 26, 2016 , ... This unique ... Scottsdale and will offer attendees an opportunity to get the lowdown on female fertility ... Over cocktails and appetizers, Dr. Jesse Hade, of Boston IVF - The Arizona Center, ...
(Date:4/26/2016)... VIENNA and ... The prize recognizes the innovation capabilities ... innovations that will benefit patients and laboratory diagnostics ... ) , Norma Instruments , ... setting products in the field of hematology, announced ...
Breaking Biology Technology:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):